bifunctional halogenation catalysts capable of controlling the regioselectivity of chlorination in complex settings

ranys, Pixabay, CC0
Background
Electrophilic aromatic chlorination is widely used in pharmaceutical development to optimize absorption, distribution, metabolism, and excretion (ADME) properties and to enable late-stage molecular diversification. However, achieving precise control over where chlorination occurs remains difficult because these reactions are typically governed by the molecule's own inherent electronic bias, often producing mixtures of different isomers—particularly problematic in complex drug molecules with multiple reactive sites. Existing Lewis acid catalysts and enzymatic systems can promote halogenation but generally cannot override this natural selectivity or prevent unwanted background reactions and polyhalogenation, limiting efficient access to specific regioisomers with potentially improved therapeutic properties.
Technology
Researchers at Stony Brook University have developed a bifunctional catalyst that combines a Lewis basic thiourea component with a fluorescein isothiocyanate-derived photosensitizer to control exactly where chlorination occurs on aromatic rings. The system uses a light-activated radical pathway to convert N-chlorosuccinimide into a highly reactive electrophilic radical cation, enabling so-called "contra-innate" chlorination at positions that would normally be disfavored by a molecule's natural electronic tendencies.
By suppressing uncatalyzed background reactions, the catalyst allows precise, ortho-selective installation of chlorine atoms on complex molecules and active pharmaceutical ingredients. This makes it possible to carry out late-stage functionalization that overrides standard electronic directing effects, giving chemists much greater control over the final structure of chlorinated drug candidates.
Advantages
- Works in diverse, complex molecular environments
- Highly specific regiocontrol on complex APIs
- Avoids reagents causing polyhalogenation
Application
- Pharmaceutical drug discovery and medicinal chemistry
- Pharmaceutical process chemistry and API manufacturing
- Specialty chemical manufacturing and supply
Inventors
jeffrey Gustafson, Professor, Chemistry
Zhao Liu, , Chemistry
Licensing Potential
Development partner - Commercial partner - Licensing
Licensing Status
Available
Licensing Contact
Jillian True, Licensing Specialist, Intellectual Property Partners, Jillian.True@stonybrook.edu,
Patent Status
Patent Application Filed
Stage of Development
Prototype Available
Tech ID
050-9558
